Peer-influenced content. Sources you trust. No registration required. This is HCN.
Roswell Park
Recent advancements in cancer research reveal the potential of using the immune system’s response to activated retrotransposons for early detection of cancers such as lung, pancreatic, and ovarian. This innovative approach could revolutionize cancer diagnostics.
Hematology/Oncology January 22nd 2024
UT Southwestern Medical Center
UT Southwestern’s pioneering use of SCINTIX biology-guided radiotherapy represents a major advancement in precision oncology, targeting bone and lung cancers with a novel approach that combines PET imaging and radiotherapy for more effective treatment.
Radiation Oncology January 16th 2024
Northwestern Medicine
Explore how metixene, a repositioned antiparkinsonian drug, emerges as a promising agent in treating metastatic breast cancer and brain metastases, redefining therapeutic approaches in oncology.
Medical Oncology January 8th 2024
Dana-Farber Cancer Institute
Belzutifan’s FDA approval, following the LITESPARK-005 trial results, represents a significant stride in treating advanced kidney cancer, offering a novel therapeutic option for patients who have exhausted standard treatments.
Johns Hopkins Medicine
Johns Hopkins University is conducting a comprehensive study on the therapeutic use of cannabis, aiming to provide insights into its efficacy and health impacts.
Internal Medicine January 3rd 2024
Groundbreaking research reveals ketamine’s potential as an effective alternative to ECT in treating treatment-resistant depression, offering new hope to millions.
Psychiatry January 3rd 2024